PKvitality is one of the winners of the Innov’up Leader PIA 2020 call for projects and the Eurostars program. The funded projects will help finance the study and elaboration of multi-analytical solutions based on K’Watch technology. The same device will be able to simultaneously monitor the evolution of several body parameters such as glucose, lactate and other analytes present in the interstitial fluid. This will improve the service to diabetic patients, athletes and improve the monitoring of other pathologies.
“Based on K’Watch Glucose, our minimally invasive Continuous Glucose Monitoring System, we intend to build a wide offer of devices and services. By monitoring new parameters, we will serve both the diabetes patients with an improved product and other therapeutic areas” says Luc Pierart, CEO of PKvitality. “We are honored by the repeated confidence of French and European public actors who support a project that will revolutionize the long-term monitoring of patients in many pathologies. This French and European support on 2 distinct projects reflects the renewed confidence in the disruptive potential of the technology developed by PKvitality.”
Know more about Innov’up Leader PIA
Know more about Eurostars